Scientist Arjan Griffioen leads cancer treatment innovation with lab and startup (Amsterdam UMC)
Could an innovative cancer treatment be used as a preventative vaccine? Arjan Griffioen and his team are determined to find out. These scientists have been developing proteins that specifically target cancer cells in the blood, leaving healthy tissue untouched. Every step of this journey—from vision to execution—has relied on the team’s dedication, as well as essential funding and investment. Spoiler alert: bringing the new treatment to market is not done overnight! Curious about the steps necessary? Watch the video to hear the full story by Arjan Griffioen and Else Huijbers.
Explore other Stories:
Entrepreneurship Education
Developing high-quality entrepreneurship education – Amsterdam’s higher education institutions have been working closely together on this since 2008. This was done in the IXAnext valorisation program between 2016 and 2021. We proudly present the main results of the IXAnext program: Ten Amsterdam entrepreneurship cases; Post experience education for alumni; Blended learning modules; A mentoring platform […]
Entrepreneurship journey of VU spin-off Optics11
Talking on Dutch television about Optics11 and the collaboration with the Dutch Ministry of Defence, raising €5 million in funding for superior life science instruments and selling products worldwide: Vrije Universiteit spin-off Optics11 is scaling up. At IXA, we were curious to find out about their journey.
Patenting: steps to bring innovation to the clinic
To make innovations in health care quickly accessible for patients, it is vital to assign value and significance to inventions (=valorization). One way to valorize is to protect the novel intellectual property by a patent. The patent underlines the importance of the finding and grants value, which is necessary for clinical development and implementation. Have […]